Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
AGM
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
AGM
Access AGM Presentation
Kazia Therapeutics Annual General Meeting
Kazia's 2023 AGM will be held as a virtual meeting on Thursday 30 November 2023.
More information
here
.
Annual Report
View Report
Chairman’s Address & Presentation
View Report
2023 AGM Presentation
View Report
AGM Results of Meeting
View Report
Annual General Meeting Outline
Adoption of Remuneration Report;
Re-Election of Steven Coffey;
The grant of up to 3,500,000 Options to Dr James Garner;
The ratification of prior issue of ATM Shares;
Approval of Additional Placement capacity under Listing Rule 7.1A;
Adoption of New Constitution; and
Approval of Proportional Takeover Provisions.
AGM Announcements
Read More
Email Alerts
For Investors
Contact Us
